Knockdown of GPR48/LGR4 in tumor cells was significantly associated with reduced phosphorylation of Ser9 of GSK3β and ERK1/2, resulting in downregulation of β-catenin signaling. This evidence concerns the gene MAPK3 and neoplasm.